论文部分内容阅读
Fleroxacin(FLRX)是日本杏林公司开发的新口服喹诺酮类抗菌剂,其抗菌谱广,对革兰氏阳性及阴性菌均有作用。口服吸收
Fleroxacin (FLRX) is a new oral quinolone antibacterial agent developed by Japan’s Kyorin Corporation. Its antibacterial spectrum is broad and has effects on Gram-positive and -negative bacteria. Oral absorption